The molecular characteristics of the individual tumor determine the treatment for each person affected by cancer. It is the cornerstone of precision oncology. And it is estimated that about 25% of patients can receive targeted therapy thanks to genomic analyzes that discover molecular alterations.
Agnostic drugs, how oncology is changing with precision medicine
